Page last updated: 2024-09-04

lonafarnib and Viremia

lonafarnib has been researched along with Viremia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bram, Y; Chiriboga, L; Cullen, J; Frankel, AS; Gerges, S; Giersch, K; Heller, B; Hrebikova, G; Huang, T; Johnson, H; Low, BE; Lutgehetmann, M; Nahass, RG; Pais, MA; Ploss, A; Schwartz, RE; Sellau, J; Seneca, K; Sharon, Y; Shirvani-Dastgerdi, E; Toettcher, JE; Wiles, MV; Winer, BY	1

Other Studies

1 other study(ies) available for lonafarnib and Viremia

Article	Year
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Science translational medicine, 2018, 06-27, Volume: 10, Issue:447 Topics: Adaptive Immunity; Animals; Disease Models, Animal; Drug Therapy, Combination; Genome, Viral; Glycoproteins; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Immunity, Innate; Immunocompetence; Lipopeptides; Mice, Inbred C57BL; Mice, Transgenic; Organic Anion Transporters, Sodium-Dependent; Piperidines; Pyridines; Symporters; Transgenes; Viremia	2018

Article

Year

Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.

Science translational medicine, 2018, 06-27, Volume: 10, Issue:447

Topics: Adaptive Immunity; Animals; Disease Models, Animal; Drug Therapy, Combination; Genome, Viral; Glycoproteins; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Immunity, Innate; Immunocompetence; Lipopeptides; Mice, Inbred C57BL; Mice, Transgenic; Organic Anion Transporters, Sodium-Dependent; Piperidines; Pyridines; Symporters; Transgenes; Viremia

2018